TY - JOUR T1 - Consequences of <em>JAG1</em> mutations JF - Journal of Medical Genetics JO - J Med Genet SP - 891 LP - 895 DO - 10.1136/jmg.40.12.891 VL - 40 IS - 12 AU - B M Kamath AU - L Bason AU - D A Piccoli AU - I D Krantz AU - N B Spinner Y1 - 2003/12/01 UR - http://jmg.bmj.com/content/40/12/891.abstract N2 - Background: Alagille syndrome (AGS) is a multi-system, autosomal dominant disorder with highly variable expressivity, caused by mutations within the Jagged1 (JAG1) gene. Methods: We studied 53 mutation positive relatives of 34 AGS probands to ascertain the frequency of clinical findings in JAG1 mutation carriers. Results: Eleven of 53 (21%) mutation positive relatives had clinical features that would have led to a diagnosis of AGS. Seventeen of the 53 (32%) relatives had mild features of AGS, revealed only after targeted evaluation following the diagnosis of a proband in their family. Twenty five of the 53 (47%) mutation positive relatives did not meet clinical criteria, and two of these individuals had no features consistent with AGS at all. The frequency of cardiac and liver disease was notably lower in the relatives than in the probands, characterising the milder end of the phenotypic spectrum. The characteristic facies of AGS was the feature with the highest penetrance, occuring almost universally in mutation positive probands and relatives. Conclusions: This study has implications for genetic counselling of families with AGS and JAG1 mutations. ER -